Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,205.00
+175.00 (8.62%)
At close: Sep 11, 2026

Kyung Nam Pharm Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
54,89160,79259,30359,00064,62370,933
Revenue Growth
-12.34%2.51%0.51%-8.70%-8.89%58.31%
Gross Profit
15,31817,22519,29816,36821,01028,674
Operating Income
952.96-242.82-3,598-3,411-8,7562,576
Net Income
-5,12210,076-20,997-7,828-3,413-5,488
Earnings Per Share
-575.49993.84-3135.24-1341.45-1837.99-1592.28
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
-50,81435,01345,47823,24827,495
Total Debt
-37,58751,33033,19339,51541,392
Net Cash (Debt)
-13,228-16,31812,285-16,268-13,898
Net Cash Growth
------
Net Cash Per Share
-1521.69-2301.432105.17-3560.18-4028.82

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
6,5411,838693.371.58-9,3422,615
Capital Expenditures
-4,908-6,490-16,823-2,851-2,306-45,582
Free Cash Flow
1,633-4,652-16,130-2,780-11,648-42,966
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
27.91%28.33%32.54%27.74%32.51%40.42%
Operating Margin
1.74%-0.40%-6.07%-5.78%-13.55%3.63%
Pretax Margin
-2.85%-5.30%-14.49%-12.53%-5.10%-10.06%
Profit Margin
-9.33%16.57%-35.41%-13.27%-5.28%-7.74%
FCF Margin
2.98%-7.65%-27.20%-4.71%-18.02%-60.57%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PE Ratio
-6.21----
Forward PE
-12.7212.7212.7212.7212.72
PS Ratio
0.791.031.011.401.371.98